Ocular Therapeutix (OCUL) Tops Q2 EPS by 3c
Ocular Therapeutix (NASDAQ: OCUL) reported Q2 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.
Ocular Therapeutix (NASDAQ: OCUL) reported Q2 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.